written by reader Who is Oxford Club touting as ‘the inventor of the world’s first AI-designed drug to enter clinical trials’? The next Intuitive Surgical?

by Simone | April 17, 2024 1:21 pm

Does anyone know company what Oxford Club[1] is touting as ‘the inventor of the world’s first AI-designed drug to enter clinical trials’? The next Intuitive Surgical?

The company is tiny today – just $500 million – but it is in position to grow dramatically.

More info from ad:
And big pharma is lining up to use its patent-protected technology. Merck is collaborating with them on three projects that could generate up to $674 million in revenue. French pharma giant Sanofi agreed to pay the company up to $5.2 billion to develop 15 new drugs. Bristol Meyers Squibb signed a $1.2 billion partnership with the company. You can see… each one of these projects is worth more than the entire market cap of this new AI stock!

Endnotes:
  1. Oxford Club: https://www.stockgumshoe.com/tag/oxford-club/

Source URL: https://www.stockgumshoe.com/2024/04/microblog-who-is-oxford-club-touting-as-the-inventor-of-the-worlds-first-ai-designed-drug-to-enter-clinical-trials-the-next-intuitive-surgical/


2 responses to “written by reader Who is Oxford Club touting as ‘the inventor of the world’s first AI-designed drug to enter clinical trials’? The next Intuitive Surgical?”

  1. Tbud says:

    I believe they are referring to Exscientia

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.